Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 04, 2022 10:49am
107 Views
Post# 34397516

RE:RE:RE:RE:RE:RE:RE:RE:Warrant Extension

RE:RE:RE:RE:RE:RE:RE:RE:Warrant ExtensionCan't disagree with that but I would say its the marketing of Aristotle that they need to work on.  They had a great CTV interview and announced the GTA roll out and than went to sleep.  There is a thing called momentum. 

Yes you have to build up your infrastructure (new hires) but you continue with the roll outs and news releases whilst marketing the heck out of your new product.  It's going to be 2 months soon since the last news.  How do you expect to create momentum unless the plan is a shock and awe news to catch the shorters off guard.



 
frewil11 wrote: Pretty straight forward here , the company has underperformed, thats why the extension , insiders don't have confidence that they will get Aristotle out to market , not yet anyways.


<< Previous
Bullboard Posts
Next >>